Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Acurx Pharmaceuticals, Inc. |
Description | Home About Management / Consultants Scientific / Corporate Advisors Board of Directors Pipeline Overview Ibezapolstat ACX-375C Publications News & Media P |
Keywords | N/A |
WebSite | acurxpharma.com |
Host IP | 174.129.30.187 |
Location | United States |
Site | Rank |
US$5,968,301
Last updated: 2023-05-02 06:22:52
acurxpharma.com has Semrush global rank of 1,773,420. acurxpharma.com has an estimated worth of US$ 5,968,301, based on its estimated Ads revenue. acurxpharma.com receives approximately 688,651 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, acurxpharma.com is safe to visit. |
Purchase/Sale Value | US$5,968,301 |
Daily Ads Revenue | US$5,510 |
Monthly Ads Revenue | US$165,277 |
Yearly Ads Revenue | US$1,983,313 |
Daily Unique Visitors | 45,911 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
acurxpharma.com. | A | 599 | IP: 174.129.30.187 |
acurxpharma.com. | NS | 86400 | NS Record: yns1.yahoo.com. |
acurxpharma.com. | NS | 86400 | NS Record: yns2.yahoo.com. |
acurxpharma.com. | MX | 600 | MX Record: 0 acurxpharma-com.mail.protection.outlook.com. |
acurxpharma.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
acurxpharma.com. | TXT | 600 | TXT Record: MS=ms82556429 |
Home About Management / Consultants Scientific / Corporate Advisors Board of Directors Pipeline Overview Ibezapolstat ACX-375C Publications News & Media Press Releases Presentations Videos Investors Overview News / Events Company Information Financial Information Stock Data SEC Filings Corporate Governance Ph2 Clinical Trial Contact Acurx Pharmaceuticals Acurx Pharmaceuticals is a publicly held, clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration. Phase 2b Clinical Study in C. difficile Infection currently enrolling Learn More © 2023 Acurx Pharmaceuticals, Inc. All Rights Reserved. Privacy Policy Disclaimer |
HTTP/1.1 301 Moved Permanently Date: Sun, 24 Oct 2021 17:28:09 GMT Server: Apache Location: http://www.acurxpharma.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 302 Moved Temporarily Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Content-Type: text/html; charset=UTF-8 Date: Sun, 24 Oct 2021 17:28:09 GMT Expires: Thu, 19 Nov 1981 08:52:00 GMT Location: https://www.acurxpharma.com/ Pragma: no-cache Server: Apache Connection: keep-alive HTTP/1.1 200 OK Date: Sun, 24 Oct 2021 17:28:10 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Content-Type: text/html; charset=UTF-8 |
Domain Name: ACURXPHARMA.COM Registry Domain ID: 2222674503_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2021-01-05T05:34:19Z Creation Date: 2018-02-03T14:44:09Z Registry Expiry Date: 2022-02-03T14:44:09Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Domain Status: ok https://icann.org/epp#ok Name Server: YNS1.YAHOO.COM Name Server: YNS2.YAHOO.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T23:58:41Z <<< |